Lilly says manufacturing and pricing swayed revenue rise
Manufacturing efficiencies and positive pricing boosted Eli Lilly’s margins in the second quarter, offsetting lower sales outside the US.
Manufacturing efficiencies and positive pricing boosted Eli Lilly’s margins in the second quarter, offsetting lower sales outside the US.
The Chinese pharmaceutical industry sets a positive outlook for regulatory harmonization as its Marketing Authorization Holder pilot program progresses.
GSK dropping 22% of its pharma portfolio
GSK will simplify its in-house manufacturing and cut CMO use by 25% under plans to strengthen its pharmaceutical business.
The adapted guideline stresses a sponsor’s responsibility to define the uncertainty associated with the medicines tested in clinical trials.
A researcher at South Africa’s Stellenbosch University (SU) says biosurfactants made by bugs in municipal wastewater could help drug makers develop new antibiotics.
Raw material supply problems that impacted its penicillin business last year have been resolved according to Reig Jofre.
Icon plc is expanding its commercialization offerings through its has acquisition of Mapi Group, a global research company.
Avantor has opened a research centre in New Jersey, US offering gene to protein expression and drug delivery contract services.